Tag: cse:lxx

January 22, 2020

Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category

Lexaria announces that it has reached a new definitive agreement to provide its patented DehydraTECHTM technology to Cannadips' cannabis products.
January 14, 2020

Lexaria Biosciences and Cannadips CBD reached definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category

Lexaria Bioscience Corp. announces that it has reached a definitive agreement to provide its patented DehydraTECHTM technology to Cannadips CBD.
January 9, 2020

Lexaria Provides Strategic Update from CEO

Lexaria Bioscience Corp's CEO Chris Bunka announces strategic update.
November 29, 2019

Lexaria Announces 2nd Tranche Closing of Non-Brokered Private Placement

Lexaria Bioscience Corp. announces it has closed the second tranche of its previously announced private placement of units as at...
November 21, 2019

Lexaria’s Technology Now Works in Less Than 10 Minutes

Lexaria Bioscience Corp. announces it has developed additional enhancements for its industry-leading DehydraTECHTM platform.
November 19, 2019

Marijuana Stocks Targeting the Cannabis Beverages Market

Marijuana stocks could see a boost as companies target the infused beverages market.
November 14, 2019

Lexaria Announces Closing of Non-Brokered Private Placement

Lexaria Bioscience Corp. announces it has closed the first tranche of its previously announced private placement of units as at...